SAMCA Chair, IV Multidisciplinary Innovation Award
17 April 2023
Monzón will host one of the three initial nodes of the IMPaCT Cohort that will study 200.000 people to improve the health of the Spanish population
18 April 2023The Lung Ambition Alliance (LAA) is a strategic initiative of AstraZeneca that was born with the ambitious objective of eliminating lung cancer as a cause of death through scientific innovation and social change. The first goal has been set to double five-year survival in lung cancer by 2025.
Scientific advances are making it possible to transform the diagnosis, treatment and management of the disease. However, barriers remain to improve and accelerate the detection, diagnosis and care of patients with lung cancer.
One of the alliance's lines of action consists of calling for innovation awards. On March 30, the Third Call for Awards for Innovation Projects for the early detection of lung cancer was opened, which aims to support the development of innovative projects in early phases for the early detection of lung cancer. The application submission period will remain open until May 30, 2023, with the winning project receiving a gross award of 30.000 euros.
The bases and application report can be consulted at the Alliance website